Sign in
Enrolling by invitationNo phase

Measuring cornea stiffness with a light-based scan in keratoconus

Measures cornea stiffness with Brillouin microscopy in adults with keratoconus, before and after treatments.

Key facts

Who runs it
The Cleveland Clinic
Where
Cleveland, United StatesSee the site
Trial code
Registry title
Corneal Biomechanical Analysis Using Brillouin Microscopy
Status
Enrolling by invitation
People taking part
220 people, planned
Started
1 Jun 2021
Expected to end
Dec 2027
Type of study
Observational, 6 groups
Treatments tested
  • Brillouin microscopy
Record updated
1 October 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with keratoconus (a thinning, bulging cornea) or with normal corneas. This includes people about to have LASIK, PRK, SMILE or CXL eye procedures. Their cornea stiffness is measured with Brillouin microscopy.

Age
18 to 60 years
Sex
All sexes
Disease stage
Keratoconus of various stages, or normal corneas. Some groups are having refractive surgery (LASIK, PRK, SMILE) or corneal cross-linking (CXL).
Earlier treatment
People who have had eye surgery before cannot join.

Main reasons for not taking part

  • Age outside 18 to 60 years
  • Past eye surgery
  • Unable to cooperate with the Brillouin microscope exam
  • Unable to give informed consent

The registry criteria, word for word

Show all 8 criteriaShow less

Who can take part

  • patients aged 18-60 with keratoconus
  • patients aged 18-60 with normal corneas,
  • patients aged 18-60 undergoing refractive surgery (LASIK, PRK, SMILE)
  • patients aged 18-60 with keratoconus undergoing CXL

Who cannot take part

  • history of previous ocular surgeries
  • outside age range
  • unable to cooperate for the Brillouin microscopic examination
  • unable to provide informed consent

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 60 years old?

Where in United States

  • Cleveland Clinic Cole Eye InstituteCleveland, United StatesEnrolling by invitation

About the trial

What the trial wants to find out

The objective of this study is to measure the Brillouin biomechanical properties in keratoconic corneas and characterize biomechanical alterations that occur after corneal procedures that inherently strengthen or weaken the cornea by evaluating the change in Brillouin metrics before and after treatments.

The 6 groups in the trial

  • 1: Normal Controls

    Patients with normal corneas without any prior surgery to serve as the control group

    Treatment: Brillouin microscopy

  • 2 Keratoconus

    Patients with various stages of keratoconus

    Treatment: Brillouin microscopy

  • 3: LASIK

    Patients with normal corneas who are undergoing laser in situ keratomileusis (LASIK)

    Treatment: Brillouin microscopy

  • Group 4: PRK

    Patients with normal corneas who are undergoing photorefractive keratectomy (PRK)

    Treatment: Brillouin microscopy

  • 5: SMILE

    Patients with normal corneas who are undergoing small incision lenticular extraction (SMILE)

    Treatment: Brillouin microscopy

  • 6: CXL

    Patients with keratoconus who are undergoing corneal cross-linking (CXL)

    Treatment: Brillouin microscopy

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Corneal Biomechanical Analysis Using Brillouin Microscopy
Plain-language title
Measuring cornea stiffness with a light-based scan in keratoconusGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 15 November 2026.
Fit questions
Built from NCT04598932, who can take part
Record updated
1 October 2026